A Pilot Trial of Serial 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Medically Inoperable Stage I Non–Small-Cell Lung Cancer Treated With Hypofractionated Stereotactic Body Radiotherapy
- 1 March 2010
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 76 (3) , 789-795
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Baseline Pulmonary Function as a Predictor for Survival and Decline in Pulmonary Function Over Time in Patients Undergoing Stereotactic Body Radiotherapy for the Treatment of Stage I Non–Small-Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung CancerJournal of Clinical Oncology, 2006
- Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 yearsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—Mature results for medically inoperable patientsLung Cancer, 2006
- Stereotactic Body Radiation TherapyThe Cancer Journal, 2006
- Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinomaCancer, 2004
- Incidence of local recurrence and second primary tumors in resected stage I lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Positron Emission Tomography for Treatment Evaluation and Recurrence Detection Compared with CT in Long-Term Follow-up Cases of Lung CancerClinical Nuclear Medicine, 1992
- Radiation therapy for medically inoperable stage I and II non-small cell lung cancerCancer Treatment Reviews, 1989